The long-range goal of this research is to help elucidate the mechanism of insulin action using cell biological and biochemical techniques. Previous studies form this laboratory and others have shown that the interaction of insulin with the plasma membrane of a variety of cell types results in the generation of a low molecular weight material which mimics insulin action on various insulin-sensitive enzymes. This mediator acts on some of the insulin sensitivity enzymes by altering phosphorylation, but its effects on other enzymes are unknown. This mediator thereby fulfills the role of an insulin second messenger for some of the intra-cellular effects of insulin. Major questions yet to be answered are: 1) What is the mediator? 2) How is it generated? 3) How does it act? The Specific Aims of this proposal are: 1. To investigate insulin-induced alterations of phospholipid metabolism in plasma membranes and to study the relationship, if any, of these responses to the generation or action of the insulin mediators. 2. To purify, chemically characterize and identify the insulin mediators by using various cell types, a battery of qualitative and quantitative assays and a variety of extraction and purification techniques. 3. To investigate the mechanism by which the insulin mediators regulate insulin-sensitive enzymes and, in particular, the low Km cyclic AMP phosphodiesterase and acetyl CoA carboxylase. The former enzyme may not be regulated by phosphorylation while the latter enzyme has its activity enhanced by insulin through phosphorylation. Insulin is the major anabolic hormone and it is important to understand how this hormone functions physiologically. With this knowledge, it may be possible to identify defects in various forms of insulin-resistant diabetes mellitus and to develop new forms of therapy for diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK028144-07
Application #
3228618
Study Section
Metabolism Study Section (MET)
Project Start
1980-07-01
Project End
1989-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
7
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lee, Y H; Harada, S; Smith, R M et al. (1996) The expression of and insulin binding to cellular thyroid hormone binding protein, but not insulin degrading enzyme, is increased during 3T3-L1 adipocytes differentiation. Biochem Biophys Res Commun 222:839-43
Harada, S; Smith, R M; Smith, J A et al. (1996) Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation. J Biol Chem 271:30222-6
Harada, S; Smith, R M; Hu, D Q et al. (1996) Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82. Biochem Biophys Res Commun 218:154-8
Shah, N; Zhang, S; Harada, S et al. (1995) Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin. Endocrinology 136:2825-35
Harada, S; Smith, R M; Smith, J A et al. (1995) Insulin-induced egr-1 expression in Chinese hamster ovary cells is insulin receptor and insulin receptor substrate-1 phosphorylation-independent. Evidence of an alternative signal transduction pathway. J Biol Chem 270:26632-8
Harada, S; Smith, R M; Smith, J A et al. (1995) Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle. Biochem J 306 ( Pt 1):21-8
Harada, S; Smith, R M; Jarett, L (1994) 1,10-Phenanthroline increases nuclear accumulation of insulin in response to inhibiting insulin degradation but has a biphasic effect on insulin's ability to increase mRNA levels. DNA Cell Biol 13:487-93
Loten, E G; Smith, J A; Jarett, L (1993) Activation and inhibition of insulin receptor autophosphorylation by trypsin treatment of intact H35 cells. Int J Biochem 25:653-60
Smith, R M; Tiesinga, J J; Shah, N et al. (1993) Genistein inhibits insulin-stimulated glucose transport and decreases immunocytochemical labeling of GLUT4 carboxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin. Arch Biochem Biophys 300:238-46
Harada, S; Smith, R M; Smith, J A et al. (1993) Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. Endocrinology 132:2293-8

Showing the most recent 10 out of 16 publications